Table 1. Prostate Cancer Hormone Therapy Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Prostate Cancer Hormone Therapy Market Restraints

Table 3. Prostate Cancer Hormone Therapy Market Trends

Table 4. Prostate Cancer Hormone Therapy Industry Policy

Table 5. Global Prostate Cancer Hormone Therapy Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Prostate Cancer Hormone Therapy Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Prostate Cancer Hormone Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Prostate Cancer Hormone Therapy Mergers & Acquisitions, Expansion Plans

Table 9. Global Prostate Cancer Hormone Therapy Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Prostate Cancer Hormone Therapy Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 12. China Prostate Cancer Hormone Therapy Revenue Market Share by Company, 2018-2023

Table 13. Global Key Players of Prostate Cancer Hormone Therapy Upstream (Raw Materials)

Table 14. Global Prostate Cancer Hormone Therapy Typical Customers

Table 15. Prostate Cancer Hormone Therapy Typical Distributors

Table 16. By Type, Global Prostate Cancer Hormone Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Application, Global Prostate Cancer Hormone Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Prostate Cancer Hormone Therapy Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 19. By Region, Global Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million

Table 20. By Country, Global Prostate Cancer Hormone Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 21. By Country, Global Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million

Table 22. By Country, Global Prostate Cancer Hormone Therapy Consumption Value Market Share, 2018-2029

Table 23. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 24. Pfizer Company Profile and Main Business

Table 25. Pfizer Prostate Cancer Hormone Therapy Models, Specifications, and Application

Table 26. Pfizer Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023

Table 27. Pfizer Recent Developments

Table 28. Astellas Company Information, Head Office, Market Area and Industry Position

Table 29. Astellas Company Profile and Main Business

Table 30. Astellas Prostate Cancer Hormone Therapy Models, Specifications, and Application

Table 31. Astellas Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023

Table 32. Astellas Recent Developments

Table 33. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

Table 34. Johnson & Johnson Company Profile and Main Business

Table 35. Johnson & Johnson Prostate Cancer Hormone Therapy Models, Specifications, and Application

Table 36. Johnson & Johnson Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023

Table 37. Johnson & Johnson Recent Developments

Table 38. AstraZeneca Company Information, Head Office, Market Area and Industry Position

Table 39. AstraZeneca Company Profile and Main Business

Table 40. AstraZeneca Prostate Cancer Hormone Therapy Models, Specifications, and Application

Table 41. AstraZeneca Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023

Table 42. AstraZeneca Recent Developments

Table 43. Bayer Company Information, Head Office, Market Area and Industry Position

Table 44. Bayer Company Profile and Main Business

Table 45. Bayer Prostate Cancer Hormone Therapy Models, Specifications, and Application

Table 46. Bayer Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023

Table 47. Bayer Recent Developments

Table 48. Merck Company Information, Head Office, Market Area and Industry Position

Table 49. Merck Company Profile and Main Business

Table 50. Merck Prostate Cancer Hormone Therapy Models, Specifications, and Application

Table 51. Merck Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023

Table 52. Merck Recent Developments

Table 53. Tolmar Company Information, Head Office, Market Area and Industry Position

Table 54. Tolmar Company Profile and Main Business

Table 55. Tolmar Prostate Cancer Hormone Therapy Models, Specifications, and Application

Table 56. Tolmar Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023

Table 57. Tolmar Recent Developments

Table 58. Zoladex Company Information, Head Office, Market Area and Industry Position

Table 59. Zoladex Company Profile and Main Business

Table 60. Zoladex Prostate Cancer Hormone Therapy Models, Specifications, and Application

Table 61. Zoladex Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023

Table 62. Zoladex Recent Developments

Table 63. Ferring Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 64. Ferring Pharmaceuticals Company Profile and Main Business

Table 65. Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Models, Specifications, and Application

Table 66. Ferring Pharmaceuticals Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023

Table 67. Ferring Pharmaceuticals Recent Developments

Table 68. Jiangsu Hengrui Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 69. Jiangsu Hengrui Pharmaceuticals Company Profile and Main Business

Table 70. Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Models, Specifications, and Application

Table 71. Jiangsu Hengrui Pharmaceuticals Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023

Table 72. Jiangsu Hengrui Pharmaceuticals Recent Developments

Table 73. CTTQ Company Information, Head Office, Market Area and Industry Position

Table 74. CTTQ Company Profile and Main Business

Table 75. CTTQ Prostate Cancer Hormone Therapy Models, Specifications, and Application

Table 76. CTTQ Prostate Cancer Hormone Therapy Revenue and Gross Margin, US$ Million, 2018-2023

Table 77. CTTQ Recent Developments

List of Figures

Figure 1. Prostate Cancer Hormone Therapy Picture

Figure 2. Global Prostate Cancer Hormone Therapy Consumption Value, (US$ million) & (2018-2029)

Figure 3. China Prostate Cancer Hormone Therapy Consumption Value, (US$ million) & (2018-2029)

Figure 4. By Consumption Value, China Prostate Cancer Hormone Therapy Market Share of Global, 2018-2029

Figure 5. Global Prostate Cancer Hormone Therapy Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 6. China Prostate Cancer Hormone Therapy Key Participants, Market Share, 2022

Figure 7. Prostate Cancer Hormone Therapy Industry Chain

Figure 8. Prostate Cancer Hormone Therapy Procurement Model

Figure 9. Prostate Cancer Hormone Therapy Sales Model

Figure 10. Prostate Cancer Hormone Therapy Sales Channels, Direct Sales, and Distribution

Figure 11. Tablet

Figure 12. Injection

Figure 13. By Type, Global Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million

Figure 14. By Type, Global Prostate Cancer Hormone Therapy Consumption Value Market Share, 2018-2029

Figure 15. Hospital

Figure 16. Clinic

Figure 17. Others

Figure 18. By Application, Global Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million

Figure 19. By Application, Global Prostate Cancer Hormone Therapy Consumption Value Market Share, 2018-2029

Figure 20. By Region, Global Prostate Cancer Hormone Therapy Consumption Value Market Share, 2018-2029

Figure 21. North America Prostate Cancer Hormone Therapy Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022

Figure 23. Europe Prostate Cancer Hormone Therapy Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022

Figure 25. Asia Pacific Prostate Cancer Hormone Therapy Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022

Figure 27. South America Prostate Cancer Hormone Therapy Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022

Figure 29. Middle East & Africa Prostate Cancer Hormone Therapy Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million

Figure 31. By Type, U.S. Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 32. By Application, U.S. Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 33. Europe Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million

Figure 34. By Type, Europe Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 35. By Application, Europe Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 36. China Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million

Figure 37. By Type, China Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 38. By Application, China Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 39. Japan Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million

Figure 40. By Type, Japan Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 41. By Application, Japan Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 42. South Korea Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million

Figure 43. By Type, South Korea Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 44. By Application, South Korea Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 45. Southeast Asia Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million

Figure 46. By Type, Southeast Asia Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 47. By Application, Southeast Asia Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 48. India Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million

Figure 49. By Type, India Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 50. By Application, India Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 51. Middle East & Africa Prostate Cancer Hormone Therapy Consumption Value, 2018-2029, US$ Million

Figure 52. By Type, Middle East & Africa Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 53. By Application, Middle East & Africa Prostate Cancer Hormone Therapy Consumption Value Market Share, 2022 VS 2029

Figure 54. Research Methodology

Figure 55. Breakdown of Primary Interviews

Figure 56. Bottom-up and Top-down Approaches

Figure 57. Top-down Approaches